I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Natalia V. Buchinskaya
33
results:
Search for persons
X
Format
Online (33)
Mediatypes
Articles (Online) (23)
OpenAccess-fulltext (10)
Languages
english (25)
russian (4)
Sorted by: Relevance
Sorted by: Year
?
1
Evaluation of etanercept (a tumor necrosis factor alpha inh..:
Buchinskaya, Natalia V.
;
Isupova, Eugenia A.
;
Vechkasova, Anastasia O.
...
Frontiers in Medicine. 10 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
Successful treatment with tocilizumab every 4 weeks of a lo..:
Kostik, Mikhail M
;
Dubko, Margarita F
;
Masalova, Vera V
...
Pediatric Rheumatology. 13 (2015) 1 - p. , 2015
Link:
https://doi.org/10.1186/..
?
3
Identification of the best cutoff points and clinical signs..:
Kostik, Mikhail M.
;
Dubko, Margarita F.
;
Masalova, Vera V.
...
Seminars in Arthritis and Rheumatism. 44 (2015) 4 - p. 417-422 , 2015
Link:
https://doi.org/10.1016/..
?
4
Evaluation of etanercept (a tumor necrosis factor alpha inh..:
Natalia V. Buchinskaya
;
Eugenia A. Isupova
;
Anastasia O. Vechkasova
...
https://www.frontiersin.org/articles/10.3389/fmed.2023.1252704/full. , 2024
Link:
https://doi.org/10.3389/..
?
5
Severe Hypocalcemia in the Adolescent as the Only Manifesta..:
Anastasia O. Vechkasova
;
Natalia V. Buchinskaya
;
Mikhail M. Kostik
...
https://vsp.spr-journal.ru/jour/article/view/3228/1302. , 2023
Link:
https://vsp.spr-journal...
?
6
How to Distinguish Attenuated Forms of Mucopolysaccharidosi..:
Natalia V. Buchinskaya
;
Nato D. Vashakmadze
;
Natalia V. Zhurkova
...
https://vsp.spr-journal.ru/jour/article/view/3097/1253. , 2023
Link:
https://vsp.spr-journal...
?
7
How to Distinguish Attenuated Forms of Mucopolysaccharidosi..:
Natalia V. Buchinskaya
;
Nato D. Vashakmadze
;
Natalia V. Zhurkova
...
https://vsp.spr-journal.ru/jour/article/view/3097. , 2023
Link:
https://doi.org/10.15690..
?
8
Progeria (Hutchinson-Gilford Syndrome): Literature Review a..:
Natalia V. Buchinskaya
;
Aida Zh. Akhenbekova
;
Aliya A. Bugybay
...
https://vsp.spr-journal.ru/jour/article/view/2954/1195. , 2022
Link:
https://vsp.spr-journal...
?
9
Progeria (Hutchinson-Gilford Syndrome): Literature Review a..:
Natalia V. Buchinskaya
;
Aida Zh. Akhenbekova
;
Aliya A. Bugybay
.
https://vsp.spr-journal.ru/jour/article/view/2954. , 2022
Link:
https://doi.org/10.15690..
?
10
Homocystinuria: Literature Review and Clinical Case Descrip..:
Natalia V. Buchinskaya
;
Eugenia A. Isupova
;
Mikhail M. Kostik
https://vsp.spr-journal.ru/jour/article/view/2138. , 2019
Link:
https://doi.org/10.15690..
?
11
How Not to Miss the Mild Forms of Mucopolysaccharidosis Typ..:
Natalia V. Buchinskaya
;
Mikhail M. Kostik
;
Oksana L. Kolobova
.
https://vsp.spr-journal.ru/jour/article/view/1979. , 2019
Link:
https://doi.org/10.15690..
?
12
Homocystinuria: Literature Review and Clinical Case Descrip..:
Natalia V. Buchinskaya
;
Eugenia A. Isupova
;
Mikhail M. Kostik
...
https://vsp.spr-journal.ru/jour/article/view/2138/871. , 2019
Link:
https://vsp.spr-journal...
?
13
Successful treatment with tocilizumab every 4 weeks of a lo..:
Kostik, Mikhail M
;
Dubko, Margarita F
;
Masalova, Vera V
...
http://www.ped-rheum.com/content/13/1/4. , 2015
Link:
http://www.ped-rheum.com..
?
14
Ytterbium difluoride YbF2: Preparation, structure, properti..:
Karimov, Denis N.
;
Buchinskaya, Irina I.
;
Ivanova, Anna G.
...
Journal of Crystal Growth. 582 (2022) - p. 126521 , 2022
Link:
https://doi.org/10.1016/..
?
15
Identification of the best cut-off points and clinical sign..:
Kostik, Mikhail M
;
Dubko, Margarita
;
Masalova, Vera
...
Pediatric Rheumatology. 12 (2014) S1 - p. , 2014
Link:
https://doi.org/10.1186/..
1-15